文献速递认知障碍与痴呆

无痴呆老年人中β-淀粉样蛋白、小胶质细胞活化、皮质厚度与代谢的关联

Association of β-Amyloid, Microglial Activation, Cortical Thickness, and Metabolism in Older Adults Without Dementia.
PubMed 文献 · Neurology · 2024-03-15

研究纳入180例无痴呆老年人,探讨血浆Aβ42/Aβ40阳性与脑脊液Aβ42/Aβ40阳性及Aβ-PET阳性的—致性与不一致性,并分析Aβ沉积、皮质厚度、葡萄糖代谢与小胶质细胞活化的关联。发现血浆Aβ42/Aβ40异常可能早于脑脊液和Aβ-PET异常,sTREM2相关小胶质细胞活化在早期与较厚皮质和较高代谢相关,在较晚期倾向于减缓Aβ累积。

要点

  • 血浆Aβ42/Aβ40阳性而PET阴性者比例是血浆阴性而PET阳性者的6.14倍。
  • Aβ-PET阴性者中血浆阳性而脑脊液阴性者比例是血浆阴性而脑脊液阳性者的8.5倍。
  • 血浆阳性/PET阴性者双侧颞上沟岸等区域Aβ累积更快,但基线FBP SUVR无差异。

核心结论

  • 血浆Aβ42/Aβ40异常可能早于脑脊液Aβ42/Aβ40和Aβ-PET异常。
  • 较高的sTREM2相关小胶质细胞活化在早期淀粉样变性阶段与较厚皮质厚度和较高代谢相关,但在相对晚期阶段倾向于减缓Aβ累积。

研究设计与样本

  • 从阿尔茨海默病神经影像学倡议队列中选取无痴呆且同时具有血浆Aβ42/Aβ40和Aβ-PET扫描的参与者。
  • 共纳入180名参与者,平均年龄72.7岁,女性占51.4%,其中96名认知正常,84名轻度认知障碍。
  • 根据复合18F-florbetapir(FBP)标准化摄取值比(SUVR)≥1.11和血浆Aβ42/Aβ40≤0.1218将参与者分为血浆±/PET±组。
  • Aβ-PET阴性个体进一步根据脑脊液Aβ42/Aβ40≤0.138分为血浆±/脑脊液±组。
  • 比较血浆±/PET±组间基线及区域FBP SUVR斜率,并分析区域FBP SUVR、FDG SUVR、皮质厚度与脑脊液可溶性髓样细胞触发受体2(sTREM2)水平的关联。

主要发现

  • 血浆阳性/PET阴性个体比例是血浆阴性/PET阳性个体的6.14倍(OR=6.143,95%CI 2.740-16.185,p<0.001)。
  • 在Aβ-PET阴性个体中,血浆阳性/脑脊液阴性个体比例是血浆阴性/脑脊液阳性个体的8.5倍(OR=8.5,95%CI 3.031-32.974,p<0.001)。
  • 血浆阳性/PET阴性个体较血浆阴性/PET阴性个体在双侧颞上沟岸(BANKSSTS)、缘上回和顶上皮质表现出更快的Aβ累积(p<0.05),但基线FBP SUVR无差异。
  • 在血浆阳性/PET阳性个体中,较高的脑脊液sTREM2水平与较慢的BANKSSTS Aβ累积相关(标准化β=-0.418,95%CI -0.681至-0.154,p=0.002)。
  • 在血浆阳性/PET阴性个体而非血浆阳性/PET阳性个体中,缘上回和顶上皮质较厚的皮质厚度和较高的葡萄糖代谢与更快的脑脊液sTREM2升高相关(p<0.05)。

关键数值与推荐

  • Aβ-PET阳性阈值:复合18F-florbetapir SUVR≥1.11。
  • 血浆Aβ42/Aβ40阳性阈值:≤0.1218。
  • 脑脊液Aβ42/Aβ40阳性阈值:≤0.138。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Plasma β-amyloid42 (Aβ42)/Aβ40 levels have shown promise in identifying Aβ-PET positive individuals. This study explored the concordance and discordance of plasma Aβ42/Aβ40 positivity (Plasma±) with CSF Aβ42/Aβ40 positivity (CSF±) and Aβ-PET positivity (PET±) in older adults without dementia. Associations of Aβ deposition, cortical thickness, glucose metabolism, and microglial activation were also investigated. METHODS: We selected participants without dementia who had concurrent plasma Aβ42/Aβ40 and Aβ-PET scans from the Alzheimer's Disease Neuroimaging Initiative cohort. Participants were categorized into Plasma±/PET± based on thresholds of composite 18F-florbetapir (FBP) standardized uptake value ratio (SUVR) ≥1.11 and plasma Aβ42/Aβ40 ≤0.1218. Aβ-PET-negative individuals were further divided into Plasma±/CSF± (CSF Aβ42/Aβ40 ≤0.138), and the concordance and discordance of Aβ42/Aβ40 in the plasma and CSF were investigated. Baseline and slopes of regional FBP SUVR were compared among Plasma±/PET± groups, and associations of regional FBP SUVR, FDG SUVR, cortical thickness, and CSF soluble Triggering Receptor Expressed on Myeloid Cell 2 (sTREM2) levels were analyzed. RESULTS: One hundred eighty participants (mean age 72.7 years, 51.4% female, 96 cognitively unimpaired, and 84 with mild cognitive impairment) were included. We found that the proportion of Plasma+/PET- individuals was 6.14 times higher (odds ratio (OR) = 6.143, 95% confidence interval (CI) 2.740-16.185, p < 0.001) than that of Plasma-/PET+ individuals, and Plasma+/CSF- individuals showed 8.5 times larger percentage (OR = 8.5, 95% CI: 3.031-32.974, p < 0.001) than Plasma-/CSF+ individuals in Aβ-PET-negative individuals. Besides, Plasma+/PET- individuals exhibited faster (p < 0.05) Aβ accumulation predominantly in bilateral banks of superior temporal sulcus (BANKSSTS) and supramarginal, and superior parietal cortices compared with Plasma-/PET- individuals, despite no difference in baseline FBP SUVRs. In Plasma+/PET+ individuals, higher CSF sTREM2 levels correlated with slower BANKSSTS Aβ accumulation (standardized β (βstd) = -0.418, 95% CI -0.681 to -0.154, p = 0.002). Conversely, thicker cortical thickness and higher glucose metabolism in supramarginal and superior parietal cortices were associated with faster (p < 0.05) CSF sTREM2 increase in Plasma+/PET- individuals rather than in Plasma+/PET+ individuals. DISCUSSION: These findings suggest that plasma Aβ42/Aβ40 abnormalities may predate CSF Aβ42/Aβ40 and Aβ-PET abnormalities. Higher sTREM2-related microglial activation is linked to thicker cortical thickness and higher metabolism in early amyloidosis stages but tends to mitigate Aβ accumulation primarily at relatively advanced stages.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Cai Y, Shi D, Lan G, et al. Association of β-Amyloid, Microglial Activation, Cortical Thickness, and Metabolism in Older Adults Without Dementia. Neurology. 2024. PMID: 38489560. doi:10.1212/WNL.0000000000209205

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。